Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Medical Device Experts

Articles with lock require a subscription to GLG News | Request a free trial
December 5, 2007
EPA for cardiovascular program
Analysis of: Amarin Commences First Clinical Trial in Cardiovascular Program | www.pipelinereview.com
Author: GLG Expert Contributor
EPA for the treatment of cadiovascular and CNS related moving disorder.
November 9, 2007
Health Care Reform: No More Room But Compromise
Analysis of: The Battle Over Health Care | www.nytimes.com
Author: GLG Expert Contributor
1. If Members of Congress and those running for president in 2008 do not recognize that this nation is in a health care crisis, we have only ourselves to blame---we put them into office to better our lives, and they are not doing the job at all, particlarly when it comes to ensuring health care services...
Ken PowellOctober 24, 2007
MRSA media attention may spur legislation and market growth
Analysis of: Putting Superbugs on the Defensive | online.wsj.com
Author: Ken Powell, President, Genesis Business Development
Two recent articles in the 10/23/07 Wall Street Journal indicate that recent media attention on "superbugs", such as MRSA and others are resulting in legislation on the state and federal level.  This legislation is likely to accelerate the unanticipated rate of growth for certain infection...
Ken PowellOctober 19, 2007
HPV test more accurate than Pap smear
Analysis of: Human Papillomavirus DNA versus Pap Screening Tests for Cervical Cancer | content.nejm.org
Author: Ken Powell, President, Genesis Business Development
A recent study of 10,154 women, published this week in the New England of Journal of Medicine, found that using the HPV (human papilloma virus) DNA test to screen for cervical cancer was twice as accurate as the traditional Pap smear.  The sensitivity of the molecular...
Eric GruffOctober 18, 2007
Are Generic Drugs Truly Bioequivalent to Their Brand Name Counterparts?
Analysis of: Generic Drugs: Dangerous Differences? | abcnews.go.com
Author: Eric Gruff, Principal, E4 Consulting
A recent study by ConsumerLab.com suggests that some generic versions of pharmaceutical products may not be bioequivalent to their brand name counterparts. The difference seems to be in the release rates for extended-release (ER) dosage forms as determined by in vitro ("test tube") analysis of...
Ken PowellOctober 18, 2007
NEJM Study BRAC1/BRAC2 Carriers
Analysis of: A Genetic Test That Very Few Need, Marketed to the Masses | www.nytimes.com
Author: Ken Powell, President, Genesis Business Development
The New England Journal of Medicine recently published a 10 year study of 1,545 breast cancer patients found the following survivial rates: *  49% for women carrying BRAC1 *  48% for women carrying BRAC2 *  51% for non-carriers *  33% of both carriers and non-carriers died...
October 17, 2007
Another ICD Related Recall - The Medtronic Fidelis ICD Lead: Increase in Fractures
Analysis of: Patients Warned as Maker Halts Sale of Heart Implant Part | www.nytimes.com
Author: GLG Expert Contributor
With the industry still struggling to recover from the relatively recent Guidant ICD recalls it is possible that this latest ICD lead recall will affect overall ICD implant rates.  It is also possible that Medtronic, the leader in the ICD market, will suffer a loss of market share due to this latest...
Eric GruffOctober 11, 2007
Wyeth's Acquisition of Haptogen Will Enhance Their Pipeline, But The Real Test is Whether This Will Lead to More Approved Therapies
Analysis of: Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery | www.pipelinereview.com
Author: Eric Gruff, Principal, E4 Consulting
Wyeth's acquisition of Haptogen, a Scottish biotechnology company specializing in novel protein-based therapeutics, is a promising development for Wyeth's biotechnology pipeline. This is a welcome addition for Wyeth, but the key will be translating the increased pipeline into additional drugs on the...
Eric GruffOctober 8, 2007
Microsoft's HealthVault: Putting Medical Information on the Web Offers Great Promise and Great Risk
Analysis of: Microsoft launches Web site to hold medical records | uk.reuters.com
Author: Eric Gruff, Principal, E4 Consulting
Microsoft's HealthVault will store medical information in an encrypted database available via the Web. In addition, there will be access to health information available to the public. Putting secured health data online seems like a great idea provided that personal information remains out of reach of...
Eric GruffOctober 5, 2007
Diabetes Patients Still Seek More Convenient Therapies. Pharma Isn't There Yet.
Analysis of: Burden of diabetes care rivals disease complications | www.reuters.com
Author: Eric Gruff, Principal, E4 Consulting
A recent Chicago-area study has made it clear that diabetics view the daily-injection routine as being equally as onerous as many of the long-term complications from the uncontrolled disease. In addition to multiple daily injections, diabetic patients usually take several concommitant medications every...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next71 to 80 of 122

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T13:45:17.613